Press Releases
|  

Press Releases

   
   
Year 2010
 
 
Wockhardt’s Q1 (Apr-Jun) FY 2011

Consolidated Sales was Rs. 922 crore
Operating Profit (EBIDTA) was Rs. 180 crore
Wockhardt’s US, UK & India Branded Business posts double-digit growth
August 13, 2010
Wockhardt receives US FDA approval for the generic version of Toprol XL® , a cardiac drug

July 23, 2010
Wockhardt’s 15 months Sales stood at Rs. 4,501 crores and Operating Profit at Rs. 823 crores

May 20, 2010
Purdue University confers Habil Khorakiwala an honorary doctorate in Pharmacy

First Indian in the past 125 years of Purdue University to receive this honour
May 15, 2010
Wockhardt launches Prostate drug Tamsulosin (Flomax) in the United States on Day-1

April 28, 2010
Wockhardt and Abbott jointly terminate the Nutrition business deal

Pharmaceutical and biotechnology major Wockhardt Limited and Abbott have jointly decided to terminate the nutritional business agreement signed by them in July 2009.
April 01, 2010
Wockhardt’s Q4 Results 2009

Consolidated Sales: Rs. 889 crore
Operating Profits: Rs 134 crore
Wockhardt’s UK & India branded business posts double-digit growth
January 25, 2010
Wockhardt receives US FDA approval for antibacterial Levofloxacin

January 13, 2010
Wockhardt receives US FDA approval for Alzheimer’s drug Memantine

January 06, 2010


Press Releases Archives
Year :
 
For press enquiries about Wockhardt, please contact

Daryl Suchitha

Associate Vice President - Corporate Relations
Wockhardt Limited
Wockhardt Towers, Bandra-Kurla Complex,
Bandra East, Mumbai 400 051, India.

Tel. : + 91 - 22 - 2653 4444.    Extension: 6303
Direct Tel.: + 91 - 22 - 2659 6303
Fax: + 91 - 22 - 2653 4242
Email: daryls@wockhardt.com

Disclaimer:
The company would like to caution that any forward-looking statements or projections made by the company, including those made in the press release announcements, are subject to risks and uncertainties that may cause actual results to differ materially from those projected.
Copyright © 2005 Wockhardt. All rights reserved.
   
This site is best viewed in 1024 X 768